Radiopharmaceuticals Market Research Reports & Industry Analysis
A radiopharmaceutical, which involves the use of radioactive agents in vivo to diagnose or treat specific diseases and conditions, generally consists of two components which determine its characteristics and clinical potential. The most common diagnostic molecular imaging agents use radioactive isotopes as the signal source. A radioactive isotope -- a radioisotope or radionuclide -- is a natural or artificially created isotope with an unstable nucleus that decays -- emitting alpha or beta particles, positrons, or gamma rays. As it decays, it loses mass and energy, until a stable isotope develops. For most elements, both stable and radioactive isotopes are known.
Examples of radioisotopes commonly combined with pharmaceutically-active molecules to form radiopharmaceuticals include technetium-99m, gallium-67, Iodine-123, Iodine-13, Thallium-201, Fluorine-18, and Indium-111.
A number of SPECT radiopharmaceuticals incorporate antibody and peptide formulations that can be targeted to specific tissue receptors, allowing one to discriminate healthy from diseased tissue with a high confidence level. However, the more specific the targeting agent is, the more difficult it is to interpret its position anatomically, since there are fewer landmarks.
Radiopharmaceuticals Industry Research & Market Reports
-
Theranostics Market by Product (Software and Services, Radiopharmaceuticals, IVD/Biomarker Screening, Diagnostic Imaging), Application, End User, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... was valued at $2.39 billion in 2024 and is projected to reach $5.77 billion by 2030, growing at a CAGR of 15.8% during the forecast period. Theranostics Market Overview Theranostics is a cutting-edge field of ... Read More
-
Global Diagnostic Radiopharmaceuticals Competitive Landscape Professional Research Report 2024
... gamma rays, which can be detected by medical imaging devices like gamma cameras or positron emission tomography (PET) scanners. When introduced into the body, these compounds selectively accumulate in specific organs or tissues, allowing healthcare ... Read More
-
Global Nuclear Medicine/Radiopharmaceuticals Competitive Landscape Professional Research Report 2024
... diseases. Radiopharmaceuticals are specially designed drugs that contain a radioactive material, typically a radionuclide. These radionuclides emit gamma rays or positrons, which can be detected by specialized imaging equipment such as gamma cameras or PET ... Read More
-
Global Radiopharmaceutical Competitive Landscape Professional Research Report 2024
... designed to target specific organs, tissues, or physiological processes within the body, allowing for the visualization or treatment of specific medical conditions. In diagnostic nuclear medicine procedures, radiopharmaceuticals emit gamma rays that can be detected ... Read More
-
Global SPECT Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. A Single Photon Emission Computed Tomography (SPECT) scan is a type of nuclear imaging test ... Read More
-
Radiopharmaceutical Market Forecasts to 2030 - Global Analysis By Type (Diagnostic, Therapeutic and Other Types), Radioisotope, Source, Application, End User and By Geography
... billion in 2024 and is expected to reach $13.06 billion by 2030 growing at a CAGR of 12.2% during the forecast period. A specific class of pharmaceutical products known as radiopharmaceuticals is made up of ... Read More
-
Radiopharmaceuticals Market by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), Application - Global Forecast 2024-2030
... to reach USD 5.48 billion in 2024, at a CAGR 6.47% to reach USD 8.00 billion by 2030. Radiopharmaceuticals are a unique category of medicinal formulations containing radioisotopes that are used in the field of ... Read More
-
Global Radiopharmaceuticals in Nuclear Medicine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... USD 4943.7 million in 2023 and is forecast to a readjusted size of USD 6857.2 million by 2030 with a CAGR of 4.8% during review period. Radiopharmaceuticals are used in the field of nuclear medicine ... Read More
-
Global Radiopharmaceuticals in Nuclear Medical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing ... Read More
-
Middle East and Africa Radiotherapy Market, By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systematic Radiotherapy/Radiopharmaceuticals); By Product (External-Beam Radiation Products, Internal Radiation Therapy Products, Radiotherapy Software); By Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer); By End User (Hospitals, Radiation Therapy Center, Specialty Clinics); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer); By End User (Hospitals, Radiation Therapy Center, Specialty Clinics); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of ... Read More
-
Radiopharmaceuticals Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Oncology, Cardiology, Neurology, Pulmonary, Urology, and Others), Type (Diagnostic and Therapeutic), Tracer Type (Tc-99m, F-18, Ga-68, TL-201, I-131, Fe-59, Lu-171, RB-82 and N-13, Cr-51 and P-32, Sc-46, Sg-269 and Hs-269, and Others), End User (Hospitals and Clinics, Diagnostic Centers, Academic and Research Institutes, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... F-18, Ga-68, TL-201, I-131, Fe-59, Lu-171, RB-82 and N-13, Cr-51 and P-32, Sc-46, Sg-269 and Hs-269, and Others), End User (Hospitals and Clinics, Diagnostic Centers, Academic and Research Institutes, and Others), and Geography (North America, ... Read More
-
Global Radiopharmaceutical Market Analysis and Forecast 2024-2030
... an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in ... Read More
-
Radiopharmaceutical Industry Research Report 2024
... molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging ... Read More
-
Global Radiopharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the ... Read More
-
Global Radiopharmaceutical Market Size, Manufacturers, Opportunities and Forecast to 2030
... radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as ... Read More
-
Global Radiopharmaceutical Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine ... Read More
-
Theranostics Market Size, Trends, Analysis, and Outlook By Product (Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software and Services), By Application (Prostate Cancer, Bone Metastasis, Others, Others), By End-User (Hospitals and Cancer Care Centers, Theranostics Centers, Research and Academic Centers), by Country, Segment, and Companies, 2024-2032
... and Academic Centers), by Country, Segment, and Companies, 2024-2032 The global Theranostics market size is poised to register 10.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Diagnostic Radiopharmaceuticals and Contrast Media Market Size, Trends, Analysis, and Outlook By Radiopharmaceuticals Imaging Modality (SPECT, PET), By Radiopharmaceuticals Application (Diagnostic, Therapeutic), By Contrast Media Type (Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media), By Contrast Media Procedure (X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound), By Contrast Media Application (Cardiovascular Disease, Oncology, Gastrointestinal Disorders, Neurological Disorders, Others), by Country, Segment, and Companies, 2024-2032
... Barium-based Contrast Media), By Contrast Media Procedure (X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound), By Contrast Media Application (Cardiovascular Disease, Oncology, Gastrointestinal Disorders, Neurological Disorders, Others), by Country, Segment, and Companies, 2024-2032 The global ... Read More
-
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Growth 2024-2030
... visualize and quantify biological processes within the body. The global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected ... Read More
-
Radiopharmaceuticals Market By End User (Hospitals and Clinics, Medical Imaging Centers, Others), By Radioisotope (Technetium 99m, Gallium 68, Iodine I, Fluorine 18, Copper 64, Strontium 89, Yttrium 90, Radium 223, Actinium 225, Lutetium 177, Copper 67, Terbium 161, Zirconium 89, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic): Global Opportunity Analysis and Industry Forecast, 2024-2033
... 67, Terbium 161, Zirconium 89, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic): Global Opportunity Analysis and Industry Forecast, 2024-2033 The radiopharmaceuticals market was valued at $7.9 billion in 2023 and is estimated ... Read More
-
2024 Global Forecast for Nuclear Medicine/Radiopharmaceuticals Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion ... Read More
-
Europe Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023 - 2030
... Theranostics Market would witness market growth of 14.8% CAGR during the forecast period (2023-2030). The Germany market dominated the Europe Theranostics Market by Country in 2022 and would continue to be a dominant market till ... Read More
-
Global Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Regional Outlook and Forecast, 2023 - 2030
... Theranostics Market size is expected to reach $5.4 billion by 2030, rising at a market growth of 15.2% CAGR during the forecast period. North America boasts a well-developed healthcare infrastructure with modern hospitals, diagnostic centers, ... Read More
-
North America Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023 - 2030
... North America Theranostics Market would witness market growth of 14.6% CAGR during the forecast period (2023-2030). The US market dominated the North America Theranostics Market by Country in 2022 and would continue to be a ... Read More
-
Global Therapeutic Radiopharmaceuticals Market Growth 2024-2030
... Therapeutic Radiopharmaceuticals is forecast to a readjusted size of US$ 4798 million by 2030 with a CAGR of 15.7% during review period. The research report highlights the growth potential of the global Therapeutic Radiopharmaceuticals market. ... Read More
Research Assistance
